Yang Lin, Li Xinyun, Huang Wei, Li Jialiang, Rao Xiangshu, Lai Yu
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
School of Traditional Chinese Medicine, Sichuan College of Traditional Chinese Medicine, Mianyang, China.
Evid Based Complement Alternat Med. 2022 Sep 1;2022:8182958. doi: 10.1155/2022/8182958. eCollection 2022.
Neurodermatitis is a common chronic inflammatory skin disease associated with neurological dysfunction. This study aimed to explore the efficacy and safety of acupuncture and moxibustion in the treatment of neurodermatitis through meta-analysis.
We comprehensively searched 9 databases, including PubMed, Cochrane Library, EMBASE, Web of Science, Scopus, China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science and Technology Journal Database (VIP), and China Biomedicine (CBM), from their inception to November 15, 2021, for published neurological and clinical randomized controlled trials (RCTs) using acupuncture to treat dermatitis. We also searched gray literature in four databases: Chinese Clinical Trials Registry, Chinese Cochrane Center, Open Grey, and GreyNet International. Two authors independently screened the data, extracted the literature, and evaluated the quality of the literature using Cochrane 5.3.3 and Review Manager 5.4.1 software.
The meta-analysis included 8 studies with a total of 728 participants, including 369 patients in the treatment group and 359 patients in the control group. Compared with conventional treatment, acupuncture significantly increased the effective rate (OR: 2.90, 95% CI: 1.78∼4.75; < 0.001) and decreased the recurrence rate after treatment (OR: 0.26, 95% CI: 0.12∼0.59; =0.001). Meanwhile, analysis of disease symptom scores showed that acupuncture group had a greater impact (OR: 3.51, 95% CI: 2.12∼4.91; < 0.00001). Furthermore, no significant difference in the adverse reaction rate was observed.
Acupuncture is safe and effective in treating neurodermatitis. However, the current level of research evidence is limited, and therefore, larger sample and high-quality RCTs are needed to confirm its safety and effectiveness. Protocol registration number is INPLASY2021110041.
神经性皮炎是一种常见的慢性炎症性皮肤病,与神经功能障碍有关。本研究旨在通过荟萃分析探讨针灸治疗神经性皮炎的疗效和安全性。
我们全面检索了9个数据库,包括PubMed、Cochrane图书馆、EMBASE、Web of Science、Scopus、中国知网(CNKI)、万方数据库、中国科技期刊数据库(VIP)和中国生物医学数据库(CBM),检索时间从建库至2021年11月15日,查找已发表的使用针灸治疗皮炎的神经学和临床随机对照试验(RCT)。我们还在四个数据库中检索了灰色文献:中国临床试验注册中心、中国Cochrane中心、Open Grey和GreyNet International。两名作者独立筛选数据、提取文献,并使用Cochrane 5.3.3和Review Manager 5.4.1软件评估文献质量。
荟萃分析纳入8项研究,共728名参与者,其中治疗组369例,对照组359例。与传统治疗相比,针灸显著提高了有效率(OR:2.90,95%CI:1.78∼4.75;P<0.001),并降低了治疗后的复发率(OR:0.26,95%CI:0.12∼0.59;P = 0.001)。同时,疾病症状评分分析表明针灸组有更大的影响(OR:3.51,95%CI:2.12∼4.91;P<0.00001)。此外,不良反应率未观察到显著差异。
针灸治疗神经性皮炎安全有效。然而,目前的研究证据水平有限,因此,需要更大样本量和高质量的RCT来证实其安全性和有效性。方案注册号为INPLASY2021110041。